Whilst ACAD might not have enough grunt. To buy out NEU. You can bet your last dollar they’ve already flagged doing more global deals here. They are building out the infrastructure to go global on neuro development drugs already.
Thar forces Jon’s hand. He needs ti know what possible offers he woukd get for a full sellout.
Then the BOD have 3 options in front of them. Go alone, license out or sell.
We are in a great position here? I wonder how all those dummy spotters from August 12 ,2019 feel about their decision to dump all their shares now?
NEU Price at posting:
$19.36 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)